![Pierluigi Antonelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierluigi Antonelli
Corporate Officer/Principal bei
FRESENIUS SE & CO. KGAA
Profil
Currently, Pierluigi Antonelli is Chief Executive Officer-Fresenius Kabi at Fresenius SE & Co. KGaA since 2023, Chairman & President, Chief Executive Officer at Fresenius Kabi AG, and Chief Executive Officer at Fresenius Kabi.
Formerly, Mr. Antonelli was Chief Executive Officer at Angelini Pharma Italia Aziende Chimiche Riunite Angelini Franc and Angelini Pharma, Inc., Chief Executive Officer at Angelini Pharma SpA from 2019 to 2023, European Vice President & Managing Director-Italy at Bristol-Myers Squibb GmbH & Co. KGaA, Head-Europe Novartis Oncology at Sandoz Deutschland GmbH from 2015 to 2019, Engagement Manager at Mckinsey & Co., Inc. (Munich) from 1994 to 1998, and Senior Vice President-Italy at Merck & Co. Education includes an MBA from Northwestern University in 1994 and an undergraduate degree from The LUISS University of Rome in 1989.
Aktive Positionen von Pierluigi Antonelli
| Unternehmen | Position | Beginn |
|---|---|---|
| FRESENIUS SE & CO. KGAA | Corporate Officer/Principal | 01.03.2023 |
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Vorstandsvorsitzender | - |
Fresenius Kabi | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Pierluigi Antonelli
| Unternehmen | Position | Ende |
|---|---|---|
Angelini Pharma SpA
 Angelini Pharma SpA Pharmaceuticals: MajorHealth Technology Develops drugs | Vorstandsvorsitzender | 06.02.2023 |
Sandoz Deutschland GmbH
 Sandoz Deutschland GmbH Financial ConglomeratesFinance Functions as an investment holding company | Corporate Officer/Principal | 01.01.2019 |
Mckinsey & Co., Inc. (Munich) | Corporate Officer/Principal | 01.01.1998 |
Bristol-Myers Squibb GmbH & Co. KGaA
 Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical medicines | Corporate Officer/Principal | - |
Merck & Co.
 Merck & Co. Real Estate DevelopmentFinance Operators of Nonresidential Buildings | Corporate Officer/Principal | - |
Ausbildung von Pierluigi Antonelli
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Fresenius SE & Co. KGaA
 Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices | Health Services |
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Health Technology |
Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA
 Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The LUISS University of Rome
 The LUISS University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fresenius Kabi | |
Sandoz Deutschland GmbH
Sandoz Deutschland GmbH Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Bristol-Myers Squibb GmbH & Co. KGaA
Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical medicines | Health Technology |
Mckinsey & Co., Inc. (Munich) | |
Angelini Pharma, Inc.
 Angelini Pharma, Inc. Specialty StoresRetail Trade Operates as a medical supply store | Retail Trade |
Merck & Co.
Merck & Co. Real Estate DevelopmentFinance Operators of Nonresidential Buildings | Finance |
Angelini Pharma SpA
Angelini Pharma SpA Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Wählen Sie MarketScreener 
